000 | 01234 a2200349 4500 | ||
---|---|---|---|
005 | 20250514015827.0 | ||
264 | 0 | _c20011228 | |
008 | 200112s 0 0 eng d | ||
022 | _a0959-8138 | ||
024 | 7 |
_a10.1136/bmj.323.7323.1228 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLyons, D | |
245 | 0 | 0 |
_aRecent advances: Psychiatry. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cNov 2001 |
||
300 |
_a1228-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlzheimer Disease _xenzymology |
650 | 0 | 4 | _aAmyloid Precursor Protein Secretases |
650 | 0 | 4 |
_aAntipsychotic Agents _xeconomics |
650 | 0 | 4 | _aAspartic Acid Endopeptidases |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aDepressive Disorder _xtherapy |
650 | 0 | 4 | _aElectromagnetic Fields |
650 | 0 | 4 |
_aEndopeptidases _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMental Disorders _xpsychology |
650 | 0 | 4 | _aStereotyping |
650 | 0 | 4 |
_aStress Disorders, Post-Traumatic _xphysiopathology |
700 | 1 | _aMcLoughlin, D M | |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 323 _gno. 7323 _gp. 1228-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.323.7323.1228 _zAvailable from publisher's website |
999 |
_c11633812 _d11633812 |